| Nusinersen in adults with 5q spinal muscular atrophy: a systematic review and meta-analysis M Gavriilaki, M Moschou, V Papaliagkas, K Notas, E Chatzikyriakou, ... Neurotherapeutics 19 (2), 464-475, 2022 | 23 | 2022 |
| Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysis M Gavriilaki, M Moschou, V Papaliagkas, K Notas, E Chatzikyriakou, ... Neuromuscular Disorders 32 (3), 185-194, 2022 | 13 | 2022 |
| Intrathecal administration of nusinersen using the ommaya reservoir in an adult with 5q-related spinal muscular atrophy type 1 and severe spinal deformity V Papaliagkas, N Foroglou, P Toulios, M Moschou, M Gavriilaki, K Notas, ... Case Reports in Neurology 13 (3), 710-715, 2022 | 7 | 2022 |
| Biomarkers of therapeutic efficacy in adolescents and adults with 5q spinal muscular atrophy: A systematic review M Gavriilaki, V Papaliagkas, A Stamperna, M Moschou, K Notas, ... Acta Neurologica Belgica 123 (5), 1735-1745, 2023 | 6 | 2023 |
| COVID-19 pandemic impact on neurologic emergencies: a single-center retrospective cohort study M Gavriilaki, E Karlafti, M Moschou, K Notas, M Arnaoutoglou, G Kaiafa, ... Pan African Medical Journal 41 (1), 2022 | 3 | 2022 |
| Switching from fingolimod to alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis: Α case series K Notas, E Papadaki, A Orologas, M Moschou, VK Kimiskidis Multiple Sclerosis and Related Disorders 38, 101517, 2020 | 3 | 2020 |
| Episodic ataxia 1 & 2: clinical characteristics, diagnosis, and management M Spilioti, A Kiryttopoulos, M Moschou, VK Kimiskidis Arch Clin Neurol 31, 79-86, 2022 | 2 | 2022 |
| Therapeutic Biomarkers in Friedreich’s Ataxia: a Systematic Review and Meta-analysis M Gavriilaki, E Chatzikyriakou, M Moschou, M Arnaoutoglou, I Sakellari, ... The Cerebellum, 1-20, 2023 | 1 | 2023 |
| The effect of repetitive transcranial magnetic stimulation on spasticity: A meta-analysis of randomized controlled trials M Moschou, V Kimiskidis, K Notas, AB Haidich, A Orologas EUROPEAN JOURNAL OF NEUROLOGY 24, 66-66, 2017 | 1 | 2017 |
| Charcot–Marie–Tooth Disease Type 2-Like Phenotype due to a Novel Variant in the Stalk Domain of KIF5A E Liouta, V Poulidou, A Frontistis, M Moschou, S Fidani, I Papoulidis, ... Neurology India 71 (3), 577-579, 2023 | | 2023 |
| Multiple Sclerosis-Related Paroxysmal Kinesigenic Dyskinesia: Long Term, Favorable Response to Lacosamide V Poulidou, M Spilioti, M Moschou, N Papanikolaou, A Drevelegas, ... Journal of Movement Disorders 15 (3), 286, 2022 | | 2022 |
| Brivaracetam for dyskinetic cerebral palsy V Papaliagkas, K Notas, E Chatzikyriakou, M Moschou, S Bostanjopoulou, ... Epileptic Disorders 24 (3), 614-616, 2022 | | 2022 |
| POMPE DISEASE: CLINICAL CHARACTERISTICS, DIAGNOSIS, AND MANAGEMENT M Moschou, M Gavriilaki, K Notas, M Arnaoutoglou, M Spilioti, ... Αρχεία Κλινικής Νευρολογίας 31, 80-91, 2022 | | 2022 |
| Nusinersen in adults with 5q spinal muscular atrophy: a systematic review and meta-analysis M Gavriilaki, M Moschou, V Papaliagkas, K Notas, E Chatzikyriakou, ... EUROPEAN JOURNAL OF NEUROLOGY 28, 63-63, 2021 | | 2021 |
| Navigated rTMS for Mapping the Language Network in Preoperative Settings: Current Status and Future Prospects A Tsitlakidis, N Foroglou, M Moschou, E Chatzikyriakou, K Kouskouras, ... Translational Neuroscience of Speech and Language Disorders, 177-204, 2020 | | 2020 |
